Terns Pharmaceuticals Inc
(TERN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | ||
| Net Income | -47,130 | -22,540 |
| Depreciation Amortization | 2,410 | 1,570 |
| Other Working Capital | 2,640 | 140 |
| Other Operating Activity | 23,970 | 0 |
| Operating Cash Flow | $-18,110 | $-20,830 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,970 | -2,600 |
| Other Investing Activity | -14,120 | 4,080 |
| Investing Cash Flow | $-16,090 | $1,480 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 46,970 | 12,550 |
| Financing Cash Flow | $46,970 | $12,550 |
| Beginning Cash Position | 1,560 | 8,350 |
| End Cash Position | 14,340 | 1,560 |
| Net Cash Flow | $12,770 | $-6,780 |
| Free Cash Flow | ||
| Operating Cash Flow | -18,110 | -20,830 |
| Free Cash Flow | -18,110 | -20,830 |